plasma cell proliferative disorder
Showing 1 - 25 of >10,000
Ovarian Failure, Perimenopausal Disorder, Hormone Disturbance Trial in Colchester (procedure, device, drug)
Active, not recruiting
- Ovarian Failure
- +2 more
- lipoaspiration harvest tSVF
- +5 more
-
Colchester, VermontFanny Island Campus Medical Building
Jul 18, 2022
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma Trial in Seattle (Allogeneic Hematopoietic
Recruiting
- Acute Lymphoblastic Leukemia
- +16 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Dec 1, 2022
Multiple Myeloma, Tumor, Plasma Cell, Tumors by Histologic Type Trial in United States (CYNK-001)
Active, not recruiting
- Multiple Myeloma
- +19 more
- CYNK-001
-
Denver, Colorado
- +8 more
May 24, 2022
Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Detroit (3'-deoxy-3'-[18F]fluorothymidine)
Recruiting
- Brain and Central Nervous System Tumors
- +8 more
- 3'-deoxy-3'-[18F]fluorothymidine
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
Mar 30, 2022
Multiple Myeloma Trial in Worldwide (Modakafusp alfa, Lenalidomide, Bortezomib)
Recruiting
- Multiple Myeloma
- Modakafusp alfa
- +5 more
-
Little Rock, Arkansas
- +53 more
Jan 12, 2023
Tissue, Blood, and Body Fluid Sample Collection From Hematologic
Recruiting
- Chronic Myeloproliferative Disorders
- +7 more
- biologic sample preservation procedure
- cytology specimen collection procedure
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center at University of North Ca
Oct 14, 2021
Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Chicago (Pemetrexed)
Completed
- Brain and Central Nervous System Tumors
- +10 more
-
Chicago, IllinoisRobert H. Lurie Comprehensive Cancer Center at Northwestern Univ
Sep 3, 2021
Collecting and Storing Blood Samples From Patients With Cancer
Withdrawn
- Brain and Central Nervous System Tumors
- +10 more
- (no location specified)
Sep 20, 2021
Multiple Myeloma, Olfactivo-gustatory Disorder, Lymphoma Trial in Montpellier (Multifactorial sensory rehabilitation workshops,
Recruiting
- Multiple Myeloma
- +2 more
- Multifactorial sensory rehabilitation workshops
- +2 more
-
Montpellier, FranceHematology Department, University Hospital Center
Dec 31, 2021
Multiple Myeloma, Immune System Diseases Trial in Chapel Hill (CAR138 T Cells)
Recruiting
- Multiple Myeloma
- Immune System Diseases
- CAR138 T Cells
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center at University of North Ca
Jan 10, 2023
National Longitudinal Cohort of Hematological Diseases
Recruiting
- Multiple Myeloma
- +17 more
-
Tianjin, Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
Jan 11, 2022
Hematopoietic and Lymphoid Cell Tumor, High Risk Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome Trial in Houston
Active, not recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- +13 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +9 more
-
Houston, TexasM D Anderson Cancer Center
Feb 8, 2022
Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia Trial in Lebanon (drug, radiation, procedure)
Recruiting
- Acute Myeloid Leukemia
- +8 more
- Cyclophosphamide
- +6 more
-
Lebanon, New HampshireDartmouth Hitchcock Medical Center, Norris Cotton Cancer Center
Apr 29, 2021
Real-World Use of Ixazomib Citrate in People With Multiple
Recruiting
- Multiple Myeloma
- No Intervention
-
Anyang, Korea, Republic of
- +20 more
Jun 15, 2022
Development of Non-Invasive Prenatal Diagnosis for Single Gene
Not yet recruiting
- Invasive PreNatal Diagnosis in a Context of Family History of Single-gene Disorders, Including
- +14 more
- Blood sample
-
Paris, FranceHôpital Cochin, Maternité Port-Royal, service de Gynécologie obs
Nov 24, 2023
Multiple Myeloma Trial in Worldwide (No intervention)
Completed
- Multiple Myeloma
- No intervention
-
Buenos Aires, Argentina
- +22 more
Aug 19, 2022
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in
Active, not recruiting
- Accelerated Phase Chronic Myelogenous Leukemia
- +125 more
- tetanus-CMV fusion peptide vaccine
- laboratory biomarker analysis
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 28, 2022
Histiocytosis Trial in Beijing (68Ga-FAPI)
Not yet recruiting
- Histiocytosis
- 68Ga-FAPI
-
Beijing, ChinaDepartment of Nuclear Medicine, Peking Union Medical College Hop
Mar 25, 2023
New Echocardiographic Indicators in Treatment of Primary
Not yet recruiting
- Multiple Myeloma
- Chemotherapy and/or autologous hematopoietic stem cell transplantation
- (no location specified)
Sep 18, 2023
Covid-19 Vaccine Responsiveness in MM and Waldenstrom
Not yet recruiting
- Multiple Myeloma
- +3 more
-
Boston, Massachusetts
- +1 more
Mar 31, 2021
Multiple Myeloma Trial in Worldwide (Daratumumab IV, Lenalidomide, Dexamethasone)
Active, not recruiting
- Multiple Myeloma
- Daratumumab IV
- +3 more
-
Birmingham, Alabama
- +211 more
Jan 17, 2023
Multiple Myeloma and Plasma Cell Tumor, Neurotoxicity Trial in Duarte (drug, genetic, other, procedure)
Completed
- Multiple Myeloma and Plasma Cell Neoplasm
- Neurotoxicity
- bortezomib
- +9 more
-
Duarte, CaliforniaCity of Hope Medical Center
Aug 17, 2021
Type1diabetes Trial in Cairo (Detection of RAGE gene polymorphism (rs1800625))
Completed
- Type1diabetes
- Detection of RAGE gene polymorphism (rs1800625)
-
Cairo, EgyptNational Institute of Diabetes and Endocrinology's
May 23, 2023
